Exelixis Inc. announced a restructuring plan on Monday that will result in the elimination of 270 jobs, or about 40 percent of the bio-tech company’s entire workforce. Exelixis, which is based in San Francisco, said the restructuring will result in a decrease of cumulative cash expenditures by $90 million through 2011. It “increases the company’s financial [...]
Continue reading...Tuesday, August 11, 2009
Seattle, Washington’s Dendreon plans to construct a $70 million manufacturing facility near Atlanta, Georgia, creating hundreds of jobs. The plant will manufacture Provenge, a treatment for patients with advanced prostate cancer. The drug is under review by the Food and Drug Administration, and the plant will open when the product is approved. Dendreon is a biotechnology company [...]
Continue reading...Thursday, July 9, 2009
Clinical research company PPD is eliminating 270 jobs in North America, almost 5% of its 5,800-person workforce. The firm blames the global economic meltdown and its effect on PPD’s clients. The cuts go into effect July 16th. Based in Wilmington, North Carolina, Pharmaceutical Product Development, or PPD, is a contract research organization that provides clinical trial development, [...]
Continue reading...Saturday, June 27, 2009
Monsanto will cut 900 jobs across the firm, or 4% of its workforce, citing an 14% drop in quarterly earnings fueled by losses to Chinese rivals producing generic versions of its herbicides. The company’s herbicide and agricultural nutrients units are being reorganized under a single executive. Founded in 1901, St. Louis, Missouri-based Monsanto is a multinational agricultural [...]
Continue reading...Friday, May 22, 2009
Broomfield, Colorado-based biotech firm ARCA Biopharma has cut 40 employees. Those laid off will get severance packages. ARCA Biopharma, formerly Nuvelo, is a biopharmaceutical company focused on developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA’s lead product candidate Gencaro, a beta-blocker and mild vasodilator, is under review by the FDA for treatment of chronic [...]
Continue reading...Wednesday, May 6, 2009
Bayer CropScience will hire 128 people over the next five years, as part of a $10.2 million expansion in Morrisville, North Carolina. The new jobs will pay an average of $100,000 per annum. The state has offered Bayer CropScience incentives of up to $2.3 million. The Bayer CropScience Research & Development Innovation Center will conduct biotech research. Bayer [...]
Continue reading...Wednesday, April 29, 2009
Seattle, Washington’s ZymoGenetics will cut 161 employees and discontinue research on cancer treatments. The firm will continue to market its only approved product, the blood-clotting compound Recothrom Thrombin, and will narrow its research focus to immunology. ZymoGenetics said the terminated employees will get severance benefits. ZymoGenetics is a biotechnology and pharmaceutical firm involved in the development of therapeutic [...]
Continue reading...Saturday, April 18, 2009
Columbus-based nonprofit BioOhio and the state Department of Development are hosting three career fairs in April and May. The fairs target job seekers for positions at bioscience businesses and research organizations in the state. The free events are expected to draw more than 400 people this year. Various companies and organizations have signed on to appear. Exhibitors [...]
Continue reading...Friday, April 10, 2009
Genetic engineering giant Amgen is cutting 100 jobs at its drug manufacturing facility in Seattle. The biotechnology firm has 17,000 employees worldwide. Amgen is merging the clinical drug trial work at its Bothell, Washington facility with operations at its company headquarters in Thousand Oaks, California. The laid-off employees can reapply for other positions in the company. Share This Story:
Continue reading...Thursday, April 2, 2009
Laboratory supply manufacturer Life Technologies will add 50 jobs in Frederick, Maryland. Company officials and Governor Martin O’Malley said the expansion will add to the more than 250 existing jobs at the plant. O’Malley said the state is investing $250,000 in the project, as part of an initiative to further the growth of Maryland’s biotechnology industry. Life Technologies, [...]
Continue reading...
Monday, March 8, 2010
2 Comments